je.st
news
AstraZeneca Announces Plans To Expand Its Frederick, Maryland Biologics Manufacturing Center
2014-12-03 07:04:35| drugdiscoveryonline News Articles
AstraZeneca recently announced plans to expand its biologics manufacturing center in Frederick, Md. The more than $200M project will increase production capacity at the facility to support AstraZeneca’s maturing pipeline, and will help position the company to keep pace with a growing demand for the development and use of biologics, which currently represent nearly 50% of AstraZeneca’s overall pipeline
Tags: center
plans
expand
manufacturing
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|